Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Metabolism: Phase II Reactions01:14

Drug Metabolism: Phase II Reactions

3.9K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
3.9K
Drug Metabolism: Phase I Reactions01:17

Drug Metabolism: Phase I Reactions

3.4K
A phase I reaction is a biochemical process that introduces a functionally reactive polar group to a substance. This transformation predominantly occurs in the liver, facilitated by the cytochrome P450 system of hemoproteins situated in the lipophilic endoplasmic reticulum of cells. The metabolite generated through this process can have varying polarities. If it is sufficiently polar, it can be easily excreted in the urine due to its water compatibility. However, if the metabolite is nonpolar,...
3.4K
Drug Biotransformation: Overview01:28

Drug Biotransformation: Overview

830
Biotransformation, also known as drug metabolism, is a vital physiological process that chemically alters drugs, facilitating their elimination from the body and terminating their action. This process involves two main phases: phase I and phase II reactions. Phase I reactions, including oxidation, reduction, and hydrolysis, introduce or unmask polar functional groups on the drug molecule, thereby increasing its water solubility. By enhancing water solubility, the drug becomes more hydrophilic...
830
Drug Distribution as One-Compartment Model and Elimination by Nonlinear Pharmacokinetics: Overview01:25

Drug Distribution as One-Compartment Model and Elimination by Nonlinear Pharmacokinetics: Overview

105
Drug administration can occur through various routes, each of which may result in a different process of elimination. This process is often mixed with nonlinear and linear processes. It's important to understand that a single drug can be metabolized into different metabolites through parallel processes.
For instance, consider the metabolism of sodium salicylate. This compound is metabolized into two distinct substances: a glucuronide and a glycine conjugate. The rate of conjugation depends...
105
Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs01:21

Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs

319
A drug's physicochemical properties fundamentally influence its metabolism. For instance, a drug's molecular size and shape critically determine its interaction with enzymes and transporters — larger drugs may face difficulty reaching enzyme active sites, altering their metabolic pathways. The pKa of a drug, which establishes its ionization state, can impact its solubility and absorption, thereby influencing metabolism.
The drug's acidity or basicity is essential in...
319
Factors Affecting Drug Biotransformation: Biological01:19

Factors Affecting Drug Biotransformation: Biological

201
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
201

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lineage-specific selection signals in the Growth arrest-specific protein 8 (GAS8) domain protein of Trypanosoma melophagium.

Scientific reports·2026
Same author

From wild shrub to cultivated host: a genetic roadmap for enhancing lac production in <i>Flemingia semialata</i>.

Frontiers in plant science·2026
Same author

BABAPPAlign: a multiple sequence alignment engine with a learned residue-level scoring function.

Bioinformatics (Oxford, England)·2026
Same author

Effect of dietary supplementation of 25-(OH) cholecalciferol on egg production and shell quality in extended laying cycle.

Tropical animal health and production·2026
Same author

Accelerated and Green Synthesis of <i>N,S</i>- and <i>N,O</i>-Heterocycles in Microdroplets.

Journal of the American Chemical Society·2026
Same author

Episodic positive selection structurally stabilizes the Arabidopsis CONSTANS-like gene COL5 indicating adaptive evolution.

Scientific reports·2026
Same journal

Branched-Chain Amino Acids (BCAAs): Metabolism and Their Roles In Inflammation Regulation and Disease.

Current drug metabolism·2026
Same journal

Corrigendum to: Nanocochleates in Clinical Trials: A Review of Current Status, Challenges, and Future Directions.

Current drug metabolism·2026
Same journal

Shenfu Decoction Extends Survival Time of Seawater-Induced Hypothermia in Rats: The Role of Metabolomics and Gut Microbiota.

Current drug metabolism·2026
Same journal

Nucleic Acid Nanomaterials Targeting Autophagy in Bone Regeneration.

Current drug metabolism·2026
Same journal

Nicotinamide N-Methyltransferase (NNMT): A Central Regulator in Hepatocellular Carcinoma Metabolism and Therapeutic Targeting - A Systematic Review.

Current drug metabolism·2026
Same journal

Chlorzoxazone-based One-Sample Method for Estimating In Vivo CYP2E1 Activity in Mice.

Current drug metabolism·2026
See all related articles

Related Experiment Video

Updated: Aug 15, 2025

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures
10:44

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures

Published on: March 28, 2017

9.9K

Machine Learning in Drug Metabolism Study.

Krishnendu Sinha1, Jyotirmoy Ghosh2, Parames Chandra Sil3

  • 1Department of Zoology, Jhargram Raj College, Jhargram-721507, India.

Current Drug Metabolism
|December 29, 2022
PubMed
Summary
This summary is machine-generated.

Machine learning models predict drug metabolism, toxicity, and interactions, accelerating drug development. These computational tools aid in understanding drug efficacy and reducing adverse effects, benefiting both pharmaceutical research and clinical practice.

Keywords:
Machine learningalgorithmsdeep learningdrug metabolismmetabolitesmolecular docking

More Related Videos

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

8.7K
An Integrated Raman Spectroscopy and Mass Spectrometry Platform to Study Single-Cell Drug Uptake, Metabolism, and Effects
07:37

An Integrated Raman Spectroscopy and Mass Spectrometry Platform to Study Single-Cell Drug Uptake, Metabolism, and Effects

Published on: January 9, 2020

9.5K

Related Experiment Videos

Last Updated: Aug 15, 2025

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures
10:44

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures

Published on: March 28, 2017

9.9K
An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

8.7K
An Integrated Raman Spectroscopy and Mass Spectrometry Platform to Study Single-Cell Drug Uptake, Metabolism, and Effects
07:37

An Integrated Raman Spectroscopy and Mass Spectrometry Platform to Study Single-Cell Drug Uptake, Metabolism, and Effects

Published on: January 9, 2020

9.5K

Area of Science:

  • Pharmacology
  • Computational Chemistry
  • Biotechnology

Background:

  • Drug metabolism transforms drugs into active or inactive metabolites, influencing efficacy and toxicity.
  • Drug metabolism is a key factor in adverse drug reactions, overdose toxicity, and reduced drug effectiveness.
  • Drug-drug interactions arise when one drug alters another's metabolism and clearance.

Purpose of the Study:

  • To review machine learning algorithms used in studying drug metabolism.
  • To highlight the application of these algorithms in predicting drug-drug interactions, toxicity, and clinical responses.
  • To emphasize the role of machine learning in accelerating drug development and optimizing combination drug therapy.

Main Methods:

  • Utilized various machine learning algorithms including Naïve Bayes, Logistic Regression, k-Nearest Neighbours, Decision Trees, Boosting, Ensemble methods, Support Vector Machines, and Artificial Neural Networks (Deep Learning).
  • Focused on the application of these algorithms for predicting drug metabolism, drug-drug interactions, drug-target interactions, clinical drug responses, metabolite identification, and sites of metabolism.
  • Leveraged advancements in deep learning for computational drug development tasks such as molecular interaction fields, molecular docking, quantitative structure-activity relationship (QSAR) studies, and quantum mechanical simulations.

Main Results:

  • Machine learning tools comprehensively study drug metabolism throughout development, predicting metabolic stability and drug-drug interactions.
  • These computational approaches offer a less resource-intensive alternative to in vitro studies for pharmaceutical companies.
  • Deep learning has significantly advanced traditional computational drug development fields, yielding unprecedented results.

Conclusions:

  • Machine learning, particularly deep learning, is revolutionizing drug metabolism studies and drug development.
  • These algorithms are crucial for predicting drug interactions, toxicity, and efficacy, aiding pharmaceutical research and clinical decision-making.
  • Computational methods accelerate drug discovery and enhance the safe and effective use of combination drug therapy.